✦ LIBER ✦

PND16 MODELING THE CLINICAL AND ECONOMIC IMPLICATIONS OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE IN GERMANY

✍ Scribed by S Guo; L Hernández; R Wasiak; M Gaudig

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modeling the Cost-Effectiveness of Galan

✍ Guk-Hee Suh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

0778 Safety of galantamine and memantine

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

P-455 - Analysis of the effect of galant

✍ E. Moruzzi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 76 KB

Safety and efficacy of galantamine (Er)

✍ Stokin, Gorazd; Ambrozic, Darja 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Nicergoline in the Treatment of Mild- to

✍ Bengt Winblad, M. Luisa Bonura, Bianca M. Rossini, Dr Angelo Battaglia 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 241 KB

P1-308 Galantamine in the treatment of m

✍ Joshua R. Shua-Haim; Mark D. Pass; Sameer Patel; Suhas Patel; Juanita Smith 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB